- Q1 2024 Kamada Ltd Earnings Call TranscriptMay 08, 2024₪21.31 (+2.65%)Earnings
- Q4 2023 Kamada Ltd Earnings Call TranscriptMar 06, 2024₪23.14Earnings
- Kamada Ltd Corporate Update Call TranscriptDec 06, 2023
- Q3 2023 Kamada Ltd Earnings Call TranscriptNov 13, 2023₪18.16 (+1.34%)Earnings
- Q2 2023 Kamada Ltd Earnings Call TranscriptAug 16, 2023₪20.43 (+6.91%)Earnings
- Q1 2023 Kamada Ltd Earnings Call TranscriptMay 24, 2023₪20.05 (+13.02%)Earnings
- Q4 2022 Kamada Ltd Earnings Call TranscriptMar 15, 2023₪15.58 (+1.70%)Earnings
- Q3 2022 Kamada Ltd Earnings Call TranscriptNov 22, 2022₪15 (-1.12%)Earnings
- Q2 2022 Kamada Ltd Earnings Call TranscriptAug 17, 2022₪16.69 (-3.36%)Earnings
- Kamada Ltd Analyst Day (Virtual) TranscriptJun 07, 2022
- Q1 2022 Kamada Ltd Earnings Call TranscriptMay 17, 2022₪16.31 (+0.06%)Earnings
- Q4 2021 Kamada Ltd Earnings Call TranscriptMar 15, 2022₪18.4 (+2.91%)Earnings
- Q3 2021 Kamada Ltd Earnings Call TranscriptNov 22, 2021₪19.25 (+11.59%)Earnings
- Q2 2021 Kamada Ltd Earnings Call TranscriptAug 11, 2021₪17.53 (-2.61%)Earnings
- Q1 2021 Kamada Ltd Earnings Call TranscriptMay 12, 2021₪19.33 (-0.21%)Earnings
- Kamada Ltd at Jefferies Virtual Plasma Summit TranscriptMar 11, 2021
- Q4 2020 Kamada Ltd Earnings Call TranscriptFeb 10, 2021₪24.04 (-8.84%)Earnings
- Q3 2020 Kamada Ltd Earnings Call TranscriptNov 11, 2020₪21.56 (-2.00%)Earnings
- Q2 2020 Kamada Ltd Earnings Call TranscriptAug 12, 2020₪27.99 (-3.42%)Earnings
- Q1 2020 Kamada Ltd Earnings Call TranscriptMay 18, 2020₪25.34 (-4.67%)Earnings
- Q4 2019 Kamada Ltd Earnings Call TranscriptFeb 12, 2020₪23.03 (-4.16%)Earnings
- Q3 2019 Kamada Ltd Earnings Call TranscriptNov 13, 2019₪19.35 (+1.31%)Earnings
- Q2 2019 Kamada Ltd Earnings Call TranscriptAug 06, 2019₪19.47 (-0.97%)Earnings
Q3 2021 Kamada Ltd Earnings Call Transcript
Hello, and welcome to the Kamada Ltd. Third Quarter 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Bob Yedid with LifeSci Advisors. Please go ahead, Bob.
Thank you, and thank you, all, for joining us. This is Bob Yedid from LifeSci Advisors. Joining me from Kamada are Amir London, Chief Executive Officer; and Chaime Orlev, Chief Financial Officer.
Earlier this morning, Kamada announced a strategic transformational transaction, positioning the company as a global leader in plasma-derived hyperimmune market through the acquisition of a portfolio of 4 FDA-approved plasma-derived commercial products from Saol Therapeutics, a privately held pharmaceutical company, as well as its financial results for the 3 and 9 months ended September 30, 2021. If you have not received these news releases, please go to the Investors page of the company's website.
Before we begin, I'd like to caution that comments made
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)